FDA 483 - Luster Products Inc - September 13, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Luster Products Inc, an OTC drug and cosmetic manufacturer in Chicago, was cited with five observations during an FDA inspection. The firm demonstrated significant deficiencies in its quality system, including a lack of a comprehensive stability testing program for hand sanitizers, inadequate laboratory controls for release testing, and failure to perform identity testing on critical components. Additionally, the quality control unit's responsibilities were not fully documented or followed, and employees lacked essential CGMP training.
ID · 3e3644c7-8daa-47d5-89df-b587da88cf21